Reaktion #69286

ord-30c27854323b4bbba2e87365642d5cfc

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeThe solvents were removed in vacuo
  2. 2
    workup.DISSOLUTIONThe resulting residue was dissolved in THF (3 mL)
  3. 3
    workup.ADDITION6N NaOH (2 mL) was added
  4. 4
    Sonstigethe mixture was partitioned between water and ethyl acetate
  5. 5
    TrocknenThe organic layer was dried over sodium sulfate
  6. 6
    Sonstigethe solvent was removed in vacuo
  7. 7
    SonstigePurification via preparative-HPLC/MS (C18
  8. 8
    Wascheneluting with a gradient of H2O and ACN containing 0.1% TFA)

Vorschrift

A solution of 4-[1-(1-cyclopentylbut-3-yn-1-yl)-1H-pyrazol-4-yl]-7-[2-(trimethylsilyl)-ethoxy]methyl-7H-pyrrolo[2,3-d]pyrimidine (52 mg, 0.12 mmol) in DCM (3 mL) and TFA (1 mL) was stirred for 2 hours. The solvents were removed in vacuo. The resulting residue was dissolved in THF (3 mL) and 6N NaOH (2 mL) was added. After stirring for 1 hour, the mixture was partitioned between water and ethyl acetate. The organic layer was dried over sodium sulfate and the solvent was removed in vacuo. Purification via preparative-HPLC/MS (C18 eluting with a gradient of H2O and ACN containing 0.1% TFA) afforded product (30 mg, 60%).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08530485B2uspto-grants-2013_09